Ginkgo Bioworks Holdings Inc
(NYSE:DNA.WS)
$
0.0276
0 (0%)
Market Cap: -
Enterprise Value: -
PE Ratio: 9,999.00
PB Ratio: 0
GF Score: 18/100 - Q4 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptFeb 29, 2024Earnings
- Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptNov 08, 2023Earnings
- Ginkgo Bioworks Holdings Inc Investor Day TranscriptOct 03, 2023
- Ginkgo Bioworks Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Ginkgo Bioworks Holdings Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 15, 2023
- Q2 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptAug 09, 2023Earnings
- Ginkgo Bioworks Holdings Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Q1 2023 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptMay 10, 2023Earnings
- Codexis Inc, Ginkgo Bioworks Holdings Inc and Twist Bioscience Corp at TD Cowen Health Care Conference- Panel TranscriptMar 06, 2023
- Q4 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptMar 01, 2023Earnings
- Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptNov 14, 2022Earnings
- Q2 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptAug 15, 2022Earnings
- Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call TranscriptJul 25, 2022
- Ginkgo Bioworks Holdings, Inc., Zymergen Inc. - M&A Call TranscriptJul 25, 2022
- Ginkgo Bioworks Holdings Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Ginkgo Bioworks Holdings Inc at William Blair Growth Stock Conference TranscriptJun 09, 2022
- Q1 2022 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptMay 16, 2022Earnings
- Q4 2021 Ginkgo Bioworks Holdings Inc Earnings Presentation TranscriptMar 28, 2022
- Ginkgo Bioworks Holdings Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Ginkgo Bioworks Holdings Inc Earnings Call TranscriptNov 15, 2021Earnings
Ginkgo Bioworks Holdings Inc at Goldman Sachs Healthcare Conference Transcript
Jun 12, 2023 / 11:40PM GMT
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
That's our queue. We'll get started. Well, thank you very much for joining us. I'm Matt Sykes, life science tools and diagnostics analyst at Goldman Sachs. I have the pleasure of introducing Anna Marie Wagner, Head of Strategy at Ginkgo Bioworks. And Anna Marie, thank you very much for joining us.
Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development
You're welcome. Thanks for having me.
Questions & Answers
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Maybe we'll just start off with sort of a brief overview of some of the key accomplishments sort of in the first half of this year and what you're sort of most excited for...
Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development
Yes. So I think one big theme that you've seen in Ginkgo really over the last year, but certainly, I
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)